U.S. health regulators on Thursday authorized the second pill against COVID-19, providing another easy-to-use medication to battle the rising tide of omicron infections. The Food and Drug Administration authorization comes one day after the agency cleared a competing drug from Pfizer. That pill is likely to become the first-choice treatment …
Read More »
Worldwide cases due to COVID-19 were approaching 250 million on Sunday as the surge from the Delta variant eases and more normal trade and tourism resume, although some countries in eastern Europe are experiencing record outbreaks. Over the last three months, the daily average number of cases has fallen by …
Read More »
A World Health Organization-led program to ensure poorer countries get fair access to COVID-19 vaccines, tests and treatments aims to secure antiviral drugs for patients with mild symptoms for as little as $10 per course, a draft document seen by Reuters says. Merck & Co’s experimental pill molnupiravir is likely …
Read More »
The plan to roll out Merck & Co’s promising antiviral pill to treat COVID-19 risks repeating the inequities of vaccine distribution, potentially leaving the nations with the greatest need once again at the back of the line, international health groups say. For example, only about 5% of Africa’s population is …
Read More »
The World Health Organization is awaiting full clinical data on the antiviral pill made by Merck & Co Inc to treat mild-to-moderate COVID-19 patients, a WHO spokesperson said on Tuesday, a day after the company said it had applied for US emergency use authorization. WHO spokesperson Christian Lindmeier, asked at …
Read More »
Merck & Co Inc said on Monday it has applied for emergency use authorization in the US for its oral drug to treat mild-to-moderate patients of COVID-19. The treatment, molnupiravir, has been developed with Ridgeback Biotherapeutics. If authorized, it would be the first oral antiviral medication. Data released last week …
Read More »
Alghadeer TV Alghadeer TV